During recent neurology conferences, migraine experts have shared noteworthy developments regarding the use of gepants, including clinical trial results, potential new indications, and recent FDA submissions. Explore the most recent updates on the use of gepants from Richard Lipton, MD, Albert Einstein College of Medicine; Stewart Tepper, MD, Dartmouth-Hitchcock Medical Center; and Jessica Ailani, MD, MedStar Georgetown University Hospital.
